PAI

Clinical trials for PAI explained in plain language.

Never miss a new study

Get alerted when new PAI trials appear

Sign up with your email to follow new studies for PAI, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Can a dissolving tablet improve recovery after a common stroke?

Disease control Not yet recruiting

This trial tests whether Y-6 sublingual tablets can help people recover from a specific type of stroke called acute perforator artery infarction. About 944 adults who have had a stroke within the past 72 hours will receive either Y-6 or a placebo twice daily for 90 days. Research…

Matched conditions: PAI

Phase: PHASE2, PHASE3 • Sponsor: Neurodawn Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated Jul 25, 2026 00:00 UTC

PAI

Get alerted when new PAI trials appear

Can a dissolving tablet improve recovery after a common stroke?